Biologics: Targets and Therapy, Volume 7, Issue (2013)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Biologics: Targets and Therapy, Volume 7, Issue (2013)

See all volumes and issues
Vol 18, 2024 Vol 17, 2023 Vol 16, 2022 Vol 15, 2021 Vol 14, 2020 Vol 13, 2019 Vol 12, 2018 Vol 11, 2017 Vol 10, 2016 Vol 9, 2015 Vol 8, 2014 Volume 7, 2013 Vol 6, 2012 Vol 5, 2011 Vol 4, 2010 Vol 3, 2009 Vol 2, 2008 Vol 1, 2007
Download citations Download PDFs Download issue

Original Research

Article
Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study
Fabrizio Cantini, Laura Niccoli, Emanuele Cassarà, Olga Kaloudi & Carlotta Nannini
Pages: 1-6
Published online: 04 Jan 2013
AbstractforDuration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study | Full Text | References | PDF (203.1 KB)
  • 91 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma
Garry M Walsh
Pages: 7-11
Published online: 09 Jan 2013
AbstractforProfile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma | Full Text | References | PDF (143.2 KB)
  • 92 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib
Ajay Nooka, Charise Gleason, Daniela Casbourne & Sagar Lonial
Pages: 13-32
Published online: 07 Dec 2022
AbstractforRelapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib | Full Text | References | PDF (505.6 KB)
  • 53 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Treatment of hemophilia B: focus on recombinant factor IX
Massimo Franchini, Francesco Frattini, Silvia Crestani, Cinzia Sissa & Carlo Bonfanti
Pages: 33-38
Published online: 12 Feb 2013
AbstractforTreatment of hemophilia B: focus on recombinant factor IX | Full Text | References | PDF (446.3 KB)
  • 283 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma
Jawaher Ansari, Syed A Hussain, Asif Ansari & John Glaholm
Pages: 39-46
Published online: 28 Feb 2013
AbstractforCritical appraisal of axitinib in the treatment of advanced renal cell carcinoma | Full Text | References | PDF (246.9 KB)
  • 53 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
Katherine Ververis, Alison Hiong, Tom C Karagiannis & Paul V Licciardi
Pages: 47-60
Published online: 25 Feb 2013
AbstractforHistone deacetylase inhibitors (HDACIs): multitargeted anticancer agents | Full Text | References | PDF (790.1 KB)
  • 254 Views
  • 53 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer
Manolo D’Arcangelo & Federico Cappuzzo
Pages: 61-68
Published online: 03 Mar 2013
AbstractforFocus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer | Full Text | References | PDF (247.1 KB)
  • 84 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
Maurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, Piercarlo Sarzi-Puttini & Fabiola Atzeni
Pages: 69-75
Published online: 15 Mar 2013
AbstractforFactors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis | Full Text | References | PDF (220.1 KB)
  • 51 Views
  • 14 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Cetuximab: its unique place in head and neck cancer treatment
Pol Specenier & Jan B Vermorken
Pages: 77-90
Published online: 15 Apr 2013
AbstractforCetuximab: its unique place in head and neck cancer treatment | Full Text | References | PDF (309.7 KB)
  • 238 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Clinical use of crizotinib for the treatment of non-small cell lung cancer
Patrick J Roberts
Pages: 91-101
Published online: 26 Apr 2013
AbstractforClinical use of crizotinib for the treatment of non-small cell lung cancer | Full Text | References | PDF (971.3 KB)
  • 78 Views
  • 14 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Hereditary angioedema: epidemiology, management, and role of icatibant
Aasia Ghazi & J Andrew Grant
Pages: 103-113
Published online: 03 May 2013
AbstractforHereditary angioedema: epidemiology, management, and role of icatibant | Full Text | References | PDF (276.1 KB)
  • 205 Views
  • 18 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Bosutinib in the management of chronic myelogenous leukemia
Gunhild Keller-von Amsberg & Philippe Schafhausen
Pages: 115-122
Published online: 06 May 2013
AbstractforBosutinib in the management of chronic myelogenous leukemia | Full Text | References | PDF (220.7 KB)
  • 94 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Review Article
New and emerging treatments for ulcerative colitis: a focus on vedolizumab
Tamsin Gledhill & Keith Bodger
Pages: 123-130
Published online: 23 May 2013
AbstractforNew and emerging treatments for ulcerative colitis: a focus on vedolizumab | Full Text | References | PDF (439.3 KB)
  • 80 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Review Article
PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
Reinhard Reuss
Pages: 131-138
Published online: 29 May 2013
AbstractforPEGylated interferon beta-1a in the treatment of multiple sclerosis – an update | Full Text | References | PDF (444.1 KB)
  • 148 Views
  • 14 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Tivozanib in the treatment of renal cell carcinoma
Mehmet Hepgur, Sarmad Sadeghi, Tanya B Dorff & David I Quinn
Pages: 139-148
Published online: 07 Dec 2022
AbstractforTivozanib in the treatment of renal cell carcinoma | Full Text | References | PDF (238 KB)
  • 163 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Review Article
A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
Johan Bennett & Christophe Dubois
Pages: 149-159
Published online: 19 Jun 2013
AbstractforA novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease | Full Text | References | PDF (1.2 MB)
  • 141 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Erythropoiesis stimulating agents: approaches to modulate activity
Angus M Sinclair
Pages: 161-174
Published online: 03 Jul 2013
AbstractforErythropoiesis stimulating agents: approaches to modulate activity | Full Text | References | PDF (1,008.9 KB)
  • 113 Views
  • 13 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
Chonlatip Pipattanaboon, Tadahiro Sasaki, Mitsuhiro Nishimura, Chayanee Setthapramote, Pannamthip Pitaksajjakul, Pornsawan Leaungwutiwong, Kriengsak Limkittikul, Orapim Puiprom, Mikiko Sasayama, Panjaporn Chaichana, Tamaki Okabayashi, Takeshi Kurosu, Ken-ichiro Ono, Pongrama Ramasoota & Kazuyoshi Ikuta
Pages: 175-187
Published online: 15 Aug 2013
AbstractforCross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus | Full Text | References | PDF (1 MB)
  • 69 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Treatment and management of myelofibrosis in the era of JAK inhibitors
Clodagh Keohane, Deepti H Radia & Claire N Harrison
Pages: 189-198
Published online: 20 Aug 2013
AbstractforTreatment and management of myelofibrosis in the era of JAK inhibitors | Full Text | References | PDF (358.5 KB)
  • 81 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Clinical utility of asthma biomarkers: from bench to bedside
Susanne JH Vijverberg, Bart Hilvering, Jan AM Raaijmakers, Jan-Willem J Lammers, Anke-Hilse Maitland-van der Zee & Leo Koenderman
Pages: 199-210
Published online: 07 Dec 2022
AbstractforClinical utility of asthma biomarkers: from bench to bedside | Full Text | References | PDF (880.3 KB)
  • 151 Views
  • 23 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
David Neal Franz
Pages: 211-221
Published online: 10 Oct 2013
AbstractforEverolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex | Full Text | References | PDF (1.8 MB)
  • 155 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck
Hua Yang, Li-Qiong Diao, Mei Shi, Rui Ma, Jian-Hua Wang, Jian-Ping Li, Feng Xiao, Ying Xue, Man Xu & Bin Zhou
Pages: 223-229
Published online: 18 Oct 2013
AbstractforEfficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck | Full Text | References | PDF (453.4 KB)
  • 50 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Corrigendum

Correction
Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
Page: 231
Published online: 07 Dec 2022
CitationforTreatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum] | Full Text | PDF (107.7 KB)
  • 48 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus
Shoji Ideno, Kaoru Sakai, Mikihiro Yunoki, Ritsuko Kubota-Koketsu, Yuji Inoue, Shota Nakamura, Teruo Yasunaga, Yoshinobu Okuno & Kazuyoshi Ikuta
Pages: 233-241
Published online: 05 Nov 2013
AbstractforImmunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus | Full Text | References | PDF (615.3 KB)
  • 73 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis
Tarun Kaushik & Muhammad Magdi Yaqoob
Pages: 243-246
Published online: 07 Dec 2022
AbstractforLessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis | Full Text | References | PDF (163.2 KB)
  • 57 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action
Kavitha Damal, Emily Stoker & John F Foley
Pages: 247-258
Published online: 27 Nov 2013
AbstractforOptimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action | Full Text | References | PDF (334.8 KB)
  • 121 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
Sylvain Mathieu, Marion Couderc, Baptiste Glace, Bruno Pereira, Anne Tournadre, Jean-Jacques Dubost & Martin Soubrier
Pages: 259-264
Published online: 02 Dec 2013
AbstractforEffects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis | Full Text | References | PDF (492.3 KB)
  • 62 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access

Corrigendum

Correction
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
Page: 265
Published online: 07 Dec 2022
CitationforNK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum] | Full Text | PDF (69 KB)
  • 41 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles